Annual EBITDA:
$109.91M+$201.22M(+220.36%)Summary
- As of today, KRYS annual EBITDA is $109.91 million, with the most recent change of +$201.22 million (+220.36%) on December 31, 2024.
- During the last 3 years, KRYS annual EBITDA has risen by +$176.14 million (+265.95%).
- KRYS annual EBITDA is now at all-time high.
Performance
KRYS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$40.85M+$3.04M(+8.04%)Summary
- As of today, KRYS quarterly EBITDA is $40.85 million, with the most recent change of +$3.04 million (+8.04%) on June 30, 2025.
- Over the past year, KRYS quarterly EBITDA has increased by +$17.80 million (+77.21%).
- KRYS quarterly EBITDA is now -4.93% below its all-time high of $42.97 million, reached on December 31, 2024.
Performance
KRYS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$158.05M+$17.80M(+12.69%)Summary
- As of today, KRYS TTM EBITDA is $158.05 million, with the most recent change of +$17.80 million (+12.69%) on June 30, 2025.
- Over the past year, KRYS TTM EBITDA has increased by +$147.72 million (+1430.15%).
- KRYS TTM EBITDA is now at all-time high.
Performance
KRYS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KRYS EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +220.4% | +77.2% | +1430.2% |
3Y3 Years | +265.9% | +247.1% | +279.7% |
5Y5 Years | +623.6% | +722.7% | +678.9% |
KRYS EBITDA Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +194.1% | -4.9% | +210.9% | at high | +216.0% |
5Y | 5-Year | at high | +194.1% | -4.9% | +210.9% | at high | +216.0% |
All-Time | All-Time | at high | +194.1% | -4.9% | +210.9% | at high | +216.0% |
KRYS EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $40.85M(+8.0%) | $158.05M(+12.7%) |
Mar 2025 | - | $37.81M(-12.0%) | $140.25M(+27.7%) |
Dec 2024 | $109.91M(+220.4%) | $42.97M(+18.0%) | $109.86M(+53.6%) |
Sep 2024 | - | $36.42M(+58.0%) | $71.54M(+592.6%) |
Jun 2024 | - | $23.05M(+210.5%) | $10.33M(+120.8%) |
Mar 2024 | - | $7.42M(+59.8%) | -$49.57M(+46.2%) |
Dec 2023 | -$91.32M(+21.8%) | $4.64M(+118.7%) | -$92.22M(+29.4%) |
Sep 2023 | - | -$24.79M(+32.7%) | -$130.55M(+4.2%) |
Jun 2023 | - | -$36.85M(-4.6%) | -$136.23M(-7.1%) |
Mar 2023 | - | -$35.22M(-4.6%) | -$127.16M(-9.5%) |
Dec 2022 | -$116.81M(-76.4%) | -$33.68M(-10.5%) | -$116.14M(-12.2%) |
Sep 2022 | - | -$30.48M(-9.7%) | -$103.55M(-17.7%) |
Jun 2022 | - | -$27.78M(-14.7%) | -$87.94M(-15.9%) |
Mar 2022 | - | -$24.21M(-14.8%) | -$75.90M(-15.9%) |
Dec 2021 | -$66.23M(-118.5%) | -$21.09M(-41.9%) | -$65.51M(-20.5%) |
Sep 2021 | - | -$14.87M(+5.5%) | -$54.34M(-11.5%) |
Jun 2021 | - | -$15.73M(-13.8%) | -$48.76M(-23.2%) |
Mar 2021 | - | -$13.82M(-39.1%) | -$39.59M(-26.3%) |
Dec 2020 | -$30.32M | -$9.93M(-7.0%) | -$31.36M(-14.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$9.28M(-41.5%) | -$27.30M(-18.2%) |
Jun 2020 | - | -$6.56M(-17.5%) | -$23.11M(-4.1%) |
Mar 2020 | - | -$5.58M(+5.0%) | -$22.20M(-5.2%) |
Dec 2019 | -$20.99M(-78.3%) | -$5.88M(-15.6%) | -$21.11M(-8.9%) |
Sep 2019 | - | -$5.08M(+10.0%) | -$19.39M(-12.5%) |
Jun 2019 | - | -$5.65M(-25.7%) | -$17.24M(-23.0%) |
Mar 2019 | - | -$4.50M(-8.1%) | -$14.01M(-19.0%) |
Dec 2018 | -$11.78M(-147.9%) | -$4.16M(-41.7%) | -$11.78M(-29.4%) |
Sep 2018 | - | -$2.93M(-20.9%) | -$9.10M(-10.2%) |
Jun 2018 | - | -$2.43M(-7.4%) | -$8.26M(-26.2%) |
Mar 2018 | - | -$2.26M(-52.2%) | -$6.54M(-37.8%) |
Dec 2017 | -$4.75M(-316.2%) | -$1.48M(+28.9%) | -$4.75M(-22.3%) |
Sep 2017 | - | -$2.09M(-193.3%) | -$3.88M(-83.4%) |
Jun 2017 | - | -$712.00K(-53.4%) | -$2.12M(-31.9%) |
Mar 2017 | - | -$464.00K(+25.0%) | -$1.60M(-40.7%) |
Dec 2016 | -$1.14M | -$619.00K(-92.2%) | -$1.14M(-118.6%) |
Sep 2016 | - | -$322.00K(-61.0%) | -$522.00K(-161.0%) |
Jun 2016 | - | -$200.00K(>-9900.0%) | -$200.00K(>-9900.0%) |
Mar 2016 | - | $0.00 | $0.00 |
FAQ
- What is Krystal Biotech, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. annual EBITDA year-on-year change?
- What is Krystal Biotech, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. quarterly EBITDA year-on-year change?
- What is Krystal Biotech, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. TTM EBITDA year-on-year change?
What is Krystal Biotech, Inc. annual EBITDA?
The current annual EBITDA of KRYS is $109.91M
What is the all-time high annual EBITDA for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high annual EBITDA is $109.91M
What is Krystal Biotech, Inc. annual EBITDA year-on-year change?
Over the past year, KRYS annual EBITDA has changed by +$201.22M (+220.36%)
What is Krystal Biotech, Inc. quarterly EBITDA?
The current quarterly EBITDA of KRYS is $40.85M
What is the all-time high quarterly EBITDA for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high quarterly EBITDA is $42.97M
What is Krystal Biotech, Inc. quarterly EBITDA year-on-year change?
Over the past year, KRYS quarterly EBITDA has changed by +$17.80M (+77.21%)
What is Krystal Biotech, Inc. TTM EBITDA?
The current TTM EBITDA of KRYS is $158.05M
What is the all-time high TTM EBITDA for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high TTM EBITDA is $158.05M
What is Krystal Biotech, Inc. TTM EBITDA year-on-year change?
Over the past year, KRYS TTM EBITDA has changed by +$147.72M (+1430.15%)